These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [French validation study of the levels of emotional awareness scale]. Bydlowski S, Corcos M, Paterniti S, Guilbaud O, Jeammet P, Consoli SM. Encephale; 2002; 28(4):310-20. PubMed ID: 12232540 [Abstract] [Full Text] [Related]
23. Cross-validation of the alcohol and cannabis use measures in the Global Appraisal of Individual Needs (GAIN) and Timeline Followback (TLFB; Form 90) among adolescents in substance abuse treatment. Dennis ML, Funk R, Godley SH, Godley MD, Waldron H. Addiction; 2004 Nov; 99 Suppl 2():120-8. PubMed ID: 15488110 [Abstract] [Full Text] [Related]
24. The natural course of cannabis use, abuse and dependence during the first decades of life. Perkonigg A, Goodwin RD, Fiedler A, Behrendt S, Beesdo K, Lieb R, Wittchen HU. Addiction; 2008 Mar; 103(3):439-49; discussion 450-1. PubMed ID: 18269364 [Abstract] [Full Text] [Related]
27. Cannabis use and dependence in a New Zealand birth cohort. Fergusson DM, Horwood LJ. N Z Med J; 2000 May 12; 113(1109):156-8. PubMed ID: 10894340 [Abstract] [Full Text] [Related]
28. [Sociodemographic profiles, addictive and mental comorbidity in cannabis users in an outpatient specific setting]. Guillem E, Pelissolo A, Vorspan F, Bouchez-Arbabzadeh S, Lépine JP. Encephale; 2009 Jun 12; 35(3):226-33. PubMed ID: 19540408 [Abstract] [Full Text] [Related]
31. Lithium carbonate in the management of cannabis withdrawal in humans: an open-label study. Winstock AR, Lea T, Copeland J. J Psychopharmacol; 2009 Jan 12; 23(1):84-93. PubMed ID: 18515451 [Abstract] [Full Text] [Related]
32. Comprehensive evaluation of bladder and urethral dysfunction symptoms: development and psychometric validation of the Urinary Symptom Profile (USP) questionnaire. Haab F, Richard F, Amarenco G, Coloby P, Arnould B, Benmedjahed K, Guillemin I, Grise P. Urology; 2008 Apr 12; 71(4):646-56. PubMed ID: 18313122 [Abstract] [Full Text] [Related]
34. Changes in cannabis use and its consequences over 3 years in a remote indigenous population in northern Australia. Clough AR, Lee KS, Cairney S, Maruff P, O'Reilly B, d'Abbs P, Conigrave KM. Addiction; 2006 May 12; 101(5):696-705. PubMed ID: 16669903 [Abstract] [Full Text] [Related]
35. Test-retest reliability of two patient-report measures for use in adults with ADHD. Matza LS, Van Brunt DL, Cates C, Murray LT. J Atten Disord; 2011 Oct 12; 15(7):557-63. PubMed ID: 20837987 [Abstract] [Full Text] [Related]
36. Adverse effects of cannabis. Prescrire Int; 2011 Jan 12; 20(112):18-23. PubMed ID: 21462790 [Abstract] [Full Text] [Related]
37. Differential responses to cannabis potency: a typology of users based on self-reported consumption behaviour. Korf DJ, Benschop A, Wouters M. Int J Drug Policy; 2007 May 12; 18(3):168-76. PubMed ID: 17689363 [Abstract] [Full Text] [Related]
38. [Validity and reliability of a screening instrument for the identification of extensive work-related problems in patients with chronic diseases (SIMBO-C)]. Streibelt M. Rehabilitation (Stuttg); 2009 Jun 12; 48(3):135-44. PubMed ID: 19513954 [Abstract] [Full Text] [Related]
39. Experiences of discrimination: validity and reliability of a self-report measure for population health research on racism and health. Krieger N, Smith K, Naishadham D, Hartman C, Barbeau EM. Soc Sci Med; 2005 Oct 12; 61(7):1576-96. PubMed ID: 16005789 [Abstract] [Full Text] [Related]
40. Cannabis and social welfare assistance: a longitudinal study. Pedersen W. Addiction; 2011 Sep 12; 106(9):1636-43. PubMed ID: 21438937 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]